Otoferlin Gene Mediated Hearing Loss clinical trials

Explore recruiting otoferlin gene mediated hearing loss clinical trials.

Recruiting otoferlin gene mediated hearing loss studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Otoferlin Gene Mediated Hearing Loss trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An Evaluation of the Long Term Safety and Efficacy of AAVAnc80-hOTOF Gene Therapy in Individuals with Sensorineural Hearing Loss due to Otoferlin Gene (OTOF) Mutations

Spain

Phase II and Phase III (Integrated) EU CTIS Study details

A Phase 1/2 Trial of AAVAnc80-hOTOF Gene Therapy in Individuals with Sensorineural Hearing Loss due to Biallelic Otoferlin Gene (OTOF) Mutations

Spain

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Otoferlin Gene Mediated Hearing Loss trials by city

Otoferlin Gene Mediated Hearing Loss in Toronto Otoferlin Gene Mediated Hearing Loss in Vancouver Otoferlin Gene Mediated Hearing Loss in Montreal Otoferlin Gene Mediated Hearing Loss in Calgary Otoferlin Gene Mediated Hearing Loss in Edmonton Otoferlin Gene Mediated Hearing Loss in Ottawa Otoferlin Gene Mediated Hearing Loss in Winnipeg Otoferlin Gene Mediated Hearing Loss in Quebec City Otoferlin Gene Mediated Hearing Loss in Hamilton Otoferlin Gene Mediated Hearing Loss in Kitchener Otoferlin Gene Mediated Hearing Loss in London Otoferlin Gene Mediated Hearing Loss in Halifax Otoferlin Gene Mediated Hearing Loss in New York Otoferlin Gene Mediated Hearing Loss in Los Angeles Otoferlin Gene Mediated Hearing Loss in Chicago Otoferlin Gene Mediated Hearing Loss in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease